<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1215987</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2023.1215987</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Bioinformatics of genome regulation and systems biology, Volume III</article-title>
<alt-title alt-title-type="left-running-head">Anashkina et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2023.1215987">10.3389/fgene.2023.1215987</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Anashkina</surname>
<given-names>Anastasia A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Orlova</surname>
<given-names>Nina G.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ignatov</surname>
<given-names>Alexander N.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Ming</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/37352/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Orlov</surname>
<given-names>Yuriy L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/47587/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>The Digital Health Institute</institution>, <institution>I.M.Sechenov First Moscow State Medical University of the Russian Ministry of Health (Sechenov University)</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Engelhardt Institute of Molecular Biology</institution>, <institution>Russian Academy of Sciences</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Mathematics</institution>, <institution>Financial University Under the Government of the Russian Federation</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Agrarian and Technological Institute</institution>, <institution>Peoples&#x2019; Friendship University of Russia (RUDN University)</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Bioinformatics</institution>, <institution>College of Life Sciences</institution>, <institution>Zhejiang University</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Institute of Cytology and Genetics</institution>, <institution>Siberian Branch of the Russian Academy of Sciences</institution>, <addr-line>Novosibirsk</addr-line>, <country>Russia</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Institute of Life Sciences and Biomedicine</institution>, <institution>Far East Federal University</institution>, <addr-line>Vladivostok</addr-line>, <country>Russia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/531759/overview">Quan Zou</ext-link>, University of Electronic Science and Technology of China, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yuriy L. Orlov, <email>orlov@d-health.institute</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1215987</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>05</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Anashkina, Orlova, Ignatov, Chen and Orlov.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Anashkina, Orlova, Ignatov, Chen and Orlov</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Genet." xlink:href="https://www.frontiersin.org/researchtopic/40408" ext-link-type="uri">Editorial on the Research Topic <article-title>Bioinformatics of genome regulation and systems biology, Volume III</article-title>
</related-article>
<kwd-group>
<kwd>bioinformatics</kwd>
<kwd>gene expression</kwd>
<kwd>regulation</kwd>
<kwd>systems biology</kwd>
<kwd>cancer biology</kwd>
<kwd>Editorial</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Computational Genomics</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>This Research Topic, &#x201c;<italic>Bioinformatics of genome regulation and systems biology, Volume III</italic>,&#x201d; continues the studies in the field of bioinformatics of gene expression presented initially in <italic>Frontiers in Genetics</italic> journal (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/8383/bioinformatics-of-genome-regulation-and-systems-biology">https://www.frontiersin.org/research-topics/8383/bioinformatics-of-genome-regulation-and-systems-biology</ext-link>) and then in the Volumes I and II (<xref ref-type="bibr" rid="B5">Orlov et al., 2021a</xref>; <xref ref-type="bibr" rid="B12">Orlov et al., 2021c</xref>) (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/14266/bioinformatics-of-genome-regulation-volume-i">https://www.frontiersin.org/research-topics/14266/bioinformatics-of-genome-regulation-volume-i</ext-link>). The materials presented in these Research Topics were initially discussed in a BGRS\SB (Bioinformatics of Genome Regulation and Structure\Systems Biology) conference series in Novosibirsk, Russia (<ext-link ext-link-type="uri" xlink:href="https://bgrssb.icgbio.ru/2022/">https://bgrssb.icgbio.ru/2022/</ext-link>) (<xref ref-type="bibr" rid="B3">Kolchanov and Orlov, 2013</xref>; <xref ref-type="bibr" rid="B10">Orlov et al., 2015</xref>), and then complemented by new works on bioinformatics and computational genomics. Gene expression regulation at the genome level remains the focus of the published papers. Materials of the conferences on genetics and genomics were presented in <italic>Frontiers in Genetics</italic> (<xref ref-type="bibr" rid="B7">Orlov and Baranova, 2020</xref>). Due to popular demand, the Research Topics were extended as Volume II (<xref ref-type="bibr" rid="B5">Orlov et al., 2021a</xref>; <xref ref-type="bibr" rid="B6">Orlov et al., 2021b</xref>) and then in this Volume III. The BGRS conference series materials on bioinformatics and gene expression regulation at gene, chromosome, and genome levels have been widely presented in the special journal Research Topic (<xref ref-type="bibr" rid="B8">Orlov et al., 2016</xref>; <xref ref-type="bibr" rid="B11">Orlov et al., 2019</xref>; <xref ref-type="bibr" rid="B13">Tatarinova et al., 2019</xref>). Recently, <italic>Frontiers in Genetics</italic> Research Topics continue discussion of these science problems (<xref ref-type="bibr" rid="B13">Tatarinova et al., 2019</xref>; <xref ref-type="bibr" rid="B6">Orlov et al., 2021b</xref>; <xref ref-type="bibr" rid="B2">Das et al., 2022</xref>; <xref ref-type="bibr" rid="B9">Orlov et al., 2022</xref>). We have to acknowledge continuing the thematic journal Research Topic &#x201c;Bioinformatics of Gene Regulations&#x201d; (<xref ref-type="bibr" rid="B6">Orlov et al., 2021b</xref>) at MDPI IJMS (<ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/journal/ijms/special_issues/MVA479KFR7">https://www.mdpi.com/journal/ijms/special_issues/MVA479KFR7</ext-link>).</p>
<p>This Research Topic presents eight papers on medical genomics and new bioinformatics tool methods. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2022.1085139/full">Dvorak et al.</ext-link> discussed the effect of intron position on gene expression regulation in their Brief research report article. Longer first introns were found to be a general property of eukaryotic gene structure and shown to contain a higher fraction of conserved sequence and different functional elements. The authors argued that the position of the longest intron in a gene can regulate gene expression.</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2023.1135320/full">Deyneko</ext-link> in his Opinion article discussed the evaluation of motif recognition methods in bioinformatics. The author suggested the performance metrics to test motif analysis software. Another methodical work was presented by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2022.1002704/full">Li et al.</ext-link> The qPCRtools package enables users to analyze the efficiency of gene amplification in qPCR data.</p>
<p>Biomedical papers present applications of bioinformatics modeling to different cancer studies. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2022.967613/full">Chen et al.</ext-link> studied the prognostic regulatory role of necroptosis in clear cell renal cell carcinoma. The necroptosis-related subtypes were identified by mining the public cohort obtained from The Cancer Genome Atlas. The clinical implication of the developed score was further validated in the patients&#x2019; cohort. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2022.984033/full">Luan et al.</ext-link> investigated the usefulness of 5-methylcytosine (5 mC) in hepatocellular carcinoma. An unsupervised clustering method was used to identify novel subtypes of hepatocellular carcinoma based on the expression of 5-methylcytosine gene signatures. The 5 mC score developed was effective in the clinical response prediction to several treatment options, including targeted therapy. Through a machine learning approach, the authors identified irinotecan (topoisomerase I inhibitor) (<xref ref-type="bibr" rid="B14">Xu et al., 2017</xref>) as a potentially promising drug for the treatment of hepatocellular carcinoma patients. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2023.1117416/full">Gu et al.</ext-link> studied hub genes and pathways associated with mitochondrial dysfunction in hypertrophy of ligamentum flavum.</p>
<p>Finally, a group of papers discovered the role of miRNA in cancer. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2022.1069637/full">Akimniyazova et al.</ext-link> studied the regulation of gene expression in esophageal adenocarcinoma by piRNAs (PIWI-interacting RNA). The authors considered the role of piRNAs as efficient regulators of mRNA translation (<xref ref-type="bibr" rid="B1">Cai et al., 2022</xref>) for esophageal adenocarcinoma candidate genes using the bioinformatics methods for piRNA&#x2013;mRNA interaction prediction. The work is an extension of the previously published Research Topic on Genome Expression Regulation by the same scientific team (<xref ref-type="bibr" rid="B4">Mukushkina et al., 2020</xref>). <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2022.1070528/full">Nersisyan et al.</ext-link> considered a novel approach for a joint analysis of isomiR and mRNA expression data in breast cancer. The application of small RNA sequencing technology led researchers to identify miRNA isoforms (isomiRs): variants of a mature miRNA differing from each other by a few nucleotides. The authors observed strong cancer subtype-specific patterns of isomiR activity, highlighting the differences between breast cancer molecular subtypes and normal tissues. This work continues the studies on miRNA regulatory interactions in cancer presented previously by the same group (<xref ref-type="bibr" rid="B15">Shkurnikov et al., 2019</xref>).</p>
<p>Overall, we are proud of the continuing Research Topics at <italic>Frontiers in Genetics</italic> we collated. Biomedical applications focusing on gene expression in chronic diseases are discussed in a new Research Topic, &#x201c;High-throughput sequencing-based investigation of chronic disease markers and mechanisms - volume II&#x201d; (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/53085/high-throughput-sequencing-based-investigation-of-chronic-disease-markers-and-mechanisms---volume-ii">https://www.frontiersin.org/research-topics/53085/high-throughput-sequencing-based-investigation-of-chronic-disease-markers-and-mechanisms---volume-ii</ext-link>) (Orlov et al., 2022). Computational plant biology applications will be considered in &#x201c;Applications of Artificial Intelligence, Machine Learning, and Deep Learning in Plant Breeding&#x201d; Research Topic (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/54136/applications-of-artificial-intelligence-machine-learning-and-deep-learning-in-plant-breeding">https://www.frontiersin.org/research-topics/54136/applications-of-artificial-intelligence-machine-learning-and-deep-learning-in-plant-breeding</ext-link>). We hope you will find this Research Topic useful to overview frontier studies in computational genomics.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>AA, NO, AI, MC, and YO organized the Research Topic as guest editors and supervised the reviewing of the manuscripts. All authors contributed to the article and approved the submitted version.</p>
</sec>
<ack>
<p>The guest editors are grateful to the authors contributing to this Research Topic and thank all the reviewers who helped improve the manuscripts. The publication was prepared with the support of the RUDN University Strategic Academic Leadership Program (AI and YO). The international cooperation was supported by the Russian Science Foundation (23-44-00030) and National Natural Science Foundation of China (32261133526).</p>
</ack>
<sec sec-type="COI-statement" id="s2">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>PIWI-interacting RNAs (piRNAs): Promising applications as emerging biomarkers for digestive system cancer</article-title>. <source>Front. Mol. Biosci.</source> <volume>27</volume> (<issue>9</issue>), <fpage>848105</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2022.848105</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tatarinova</surname>
<given-names>T. V.</given-names>
</name>
<name>
<surname>Galieva</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Editorial: Association between individuals&#x2019; genomic ancestry and variation in disease susceptibility</article-title>. <source>Front. Genet.</source> <volume>13</volume>, <fpage>831320</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2022.831320</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolchanov</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Introductory note for BGRS-2012 special issue</article-title>. <source>J. Bioinforma. Comput. Biol.</source> <volume>11</volume> (<issue>1</issue>), <fpage>1302001</fpage>. <pub-id pub-id-type="doi">10.1142/S0219720013020010</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukushkina</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Aisina</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pyrkova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ryskulova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Labeit</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ivashchenko</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>
<italic>In silico</italic> prediction of miRNA interactions with candidate atherosclerosis gene mRNAs</article-title>. <source>Front. Genet.</source> <volume>11</volume>, <fpage>605054</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2020.605054</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Anashkina</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Klimontov</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Baranova</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>Medical genetics, genomics and bioinformatics aid in understanding molecular mechanisms of human diseases</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>, <fpage>9962</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22189962</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Anashkina</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Tatarinova</surname>
<given-names>T. V.</given-names>
</name>
<name>
<surname>Baranova</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>Editorial: Bioinformatics of genome regulation, volume II</article-title>. <source>Front. Genet.</source> <volume>12</volume>, <fpage>795257</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2021.795257</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Baranova</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Editorial: Bioinformatics of genome regulation and Systems biology</article-title>. <source>Front. Genet.</source> <volume>11</volume>, <fpage>625</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2020.00625</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Baranova</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Markel</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Computational models in genetics at BGRS\SB-2016: Introductory note</article-title>. <source>BMC Genet.</source> <volume>17</volume> (<issue>3</issue>), <fpage>155</fpage>. <pub-id pub-id-type="doi">10.1186/s12863-016-0465-3</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Sekacheva</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Editorial: High-Throughput sequencing-based investigation of chronic disease markers and mechanisms</article-title>. <source>Front. Genet.</source> <volume>13</volume>, <fpage>922206</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2022.922206</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Hofest&#xe4;dt</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Kolchanov</surname>
<given-names>N. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Introductory note for BGRS\SB-2014 special issue</article-title>. <source>J. Bioinform. Comput. Biol.</source> <volume>13</volume>, <fpage>1502001</fpage>. <pub-id pub-id-type="doi">10.1142/S0219720015020011</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Hofest&#xe4;dt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tatarinova</surname>
<given-names>T. V.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Bioinformatics research at BGRS \ SB-2018</article-title>. <source>J. Bioinform. Comput. Biol.</source> <volume>17</volume>, <fpage>1902001</fpage>. <pub-id pub-id-type="doi">10.1142/S0219720019020013</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Tatarinova</surname>
<given-names>T. V.</given-names>
</name>
<name>
<surname>Oparina</surname>
<given-names>N. Y.</given-names>
</name>
<name>
<surname>Galieva</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Baranova</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2021c</year>). <article-title>Editorial: Bioinformatics of genome regulation, volume I</article-title>. <source>Front. Genet.</source> <volume>12</volume>, <fpage>803273</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2021.803273</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shkurnikov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nikulin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nersisyan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Poloznikov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Baranova</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>LAMA4-regulating miR-4274 and its host gene SORCS2 play a role in IGFBP6-dependent effects on phenotype of basal-like breast cancer</article-title>. <source>Front. Mol. Biosci.</source> <volume>6</volume>, <fpage>122</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2019.00122</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tatarinova</surname>
<given-names>T. V.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Orlov</surname>
<given-names>Y. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Bioinformatics research at BGRS-2018</article-title>. <source>BMC Bioinforma.</source> <volume>20</volume> (<issue>1</issue>), <fpage>33</fpage>. <pub-id pub-id-type="doi">10.1186/s12859-018-2566-7</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1</article-title>. <source>Br. J. Cancer</source> <volume>116</volume> (<issue>8</issue>), <fpage>1027</fpage>&#x2013;<lpage>1036</lpage>. <pub-id pub-id-type="doi">10.1038/bjc.2017.55</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>